Hikma Recalls Sodium Chloride Injection Vials Due to pH Failures
Hikma Pharmaceuticals is recalling 1.3 million vials of Sodium Chloride Injection USP 0.9% because pH test results were out of specification.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or hospitalizations, fitting the criteria for a moderate severity score.
Plain-English summary
Hikma Pharmaceuticals USA Inc. is recalling 1,324,072 vials of Sodium Chloride Injection, USP, 0.9%, 2mL Single Dose Vials. The recall was initiated because out-of-specification pH test results were found in the product. The affected vials are distributed nationwide in the USA.
The specific lots subject to this recall are 048315 (EXP 4/2021), 068320 (EXP 6/2021), 128302 (EXP 12/2021), and 099349 (EXP 9/2022). The product is a prescription-only medication manufactured by West-ward in Eatontown, NJ, and is intended for intramuscular, intravenous, or subcutaneous use.
Healthcare providers and patients should check their inventory and records for these specific lot numbers. If the product is found, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures. No specific consumer action is required for the general public as this is a prescription product.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 1,324,072
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 048315 EXP 4/2021
- 068320 EXP 6/2021
- 128302 EXP 12/2021
- 099349 EXP 9/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- HighSpectra sodium chloride ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighFresenius Kabi 500 mL saline freeflex bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighBD-distributed 50 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 1,000 mL sodium chloride bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi half-normal saline 250 mL bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
Same manufacturer · Hikma Pharmaceuticals USA Inc.
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateAlendronate Sodium Oral Solution Recalled for Out-of-Specification Assay Results
FDA (Drugs) · 2026-05-06
- ModerateLorazepam injection vials failed the total related compounds impurity specification
FDA (Drugs) · 2025-08-06
- SevereFDA Recalls Acetaminophen Injection Due to Labeling Mix-up
FDA (Drugs) · 2024-08-28
- HighMorphine Sulfate Ampuls Recalled for Expired Filters in Cartons
FDA (Drugs) · 2024-03-27
Same hazard · ph failure
See all →- ModerateDiclofenac topical gel recalled after failing pH specifications
FDA (Drugs) · 2026-01-28
- LowFerring Recalls Menopur Due to Out-of-Specification pH in Diluent
FDA (Drugs) · 2021-03-17
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-11-25
- LowRemedyRepack Recalls Metoprolol Tartrate Injection Due to pH Failures
FDA (Drugs) · 2018-11-21